ArticleGenomics, proteomics & bioinformatics2025
iRUNNER: A Baseline Mutation Burden Regression for Identifying Gene Interaction Between Rare Variants for Diseases.
Article in Genomics, proteomics & bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Screening for candidate genes and cell populations associated with atherosclerotic calcification using single-cell RNA sequencing.Mammalian genome : official journal of the International Mammalian Genome Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Genetic interactions play a crucial role in elucidating the susceptibility and etiology of complex multifactorial diseases. Despite significant efforts to identify disease-associated nonlinear effects in genome-wide association studies, efficient methods for detecting the epistatic impact of rare variants remain lacking. In this study, we propose iRUNNER, a novel and powerful mutation burden test focused on analyzing the interaction effects of rare variants on a binary trait. In contrast to conventional association tests that compare cases with controls, iRUNNER evaluates the relative enrichment of rare variant interaction burden of pairwise genes in patients against its baseline, estimated by a recursive truncated negative-binomial regression model that leverages multiple genomic features from public databases. Extensive simulations demonstrate that iRUNNER outperforms existing epistasis tests in statistical power and maintains reasonable type I error rates even when population stratification exists in control samples. When applied to real datasets from five complex diseases, iRUNNER yielded substantial gains in gene-gene interaction detection. Notably, the majority of these signals were missed by alternative methods, especially in small- to medium-sized samples. Furthermore, we found that these identified gene pairs of each trait can form interconnected networks, which may provide valuable insights into the underlying molecular mechanisms. We have implemented iRUNNER as a module in our integrative platform KGGSeq (http://pmglab.top/kggseq/) that enables rapid testing of pairwise interactions among all possible non-synonymous rare coding variants within hours.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.